Iranian Journal of Radiology

Published by: Kowsar

Rate of Malignancy in Exophytic Thyroid Nodules

Fatma Dilek Dellal 1 , * , Husniye Baser 1 , Dilek Arpaci 2 , Abbas Ali Tam 3 , Didem Ozdemir 3 , Aydan Kilicarslan 4 , Ersin Gurkan Dumlu 5 , Reyhan Ersoy 3 and Bekir Cakir 3
Authors Information
1 Department of Endocrinology and Metabolism, Ataturk Training and Research Hospital, Ankara, Turkey
2 Department of Endocrinology and Metabolism, Bulent Ecevit University, Zonguldak, Turkey
3 Department of Endocrinology and Metabolism, Faculty of Medicine, Yildirim Beyazit University, Ankara, Turkey
4 Department of Pathology, Faculty of Medicine, Yildirim Beyazit University, Ankara, Turkey
5 Department of Surgery, Faculty of Medicine, Yildirim Beyazit University, Ankara, Turkey
Article information
  • Iranian Journal of Radiology: April 2017, 14 (2); e41141
  • Published Online: February 25, 2017
  • Article Type: Research Article
  • Received: August 3, 2016
  • Revised: November 28, 2016
  • Accepted: January 25, 2017
  • DOI: 10.5812/iranjradiol.41141

To Cite: Dellal F D, Baser H, Arpaci D, Tam A A, Ozdemir D, et al. Rate of Malignancy in Exophytic Thyroid Nodules, Iran J Radiol. 2017 ; 14(2):e41141. doi: 10.5812/iranjradiol.41141.

Copyright © 2017, Tehran University of Medical Sciences and Iranian Society of Radiology. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016; 26(1): 1-133[DOI][PubMed]
  • 2. Terzioglu T, Tezelman S, Onaran Y, Tanakol R. Concurrent hyperthyroidism and thyroid carcinoma. Br J Surg. 1993; 80(10): 1301-2[PubMed]
  • 3. Baskin Sr HJ, Duick DS, Levine RA. Thyroid ultrasound and ultrasound-guided FNA. 2012;
  • 4. Keles E, Ozkara S, Karlidag T, Ozercan IH. Thyroid tissue connected to normally located thyroid gland: ectopic or exophytic? Case Rep Otolaryngol. 2012; 2012: 681823[DOI][PubMed]
  • 5. Kim DW, Jung SJ, Baek HJ. Computed tomography features of benign and malignant solid thyroid nodules. Acta Radiol. 2015; 56(10): 1196-202[DOI][PubMed]
  • 6. Chaudhary V, Bano S. Thyroid ultrasound. Indian J Endocrinol Metab. 2013; 17(2): 219-27[DOI][PubMed]
  • 7. Yamashiro I, Saito O, Chammas MC, Cerri GG. Achados ultra-sonográficos na tireoidite. Radiologia Brasileira. 2007; 40(2): 75-9[DOI]
  • 8. Cibas ES, Ali SZ. The Bethesda System for Reporting Thyroid Cytopathology. Thyroid. 2009; 19(11): 1159-65[DOI][PubMed]
  • 9. Kratky J, Vitkova H, Bartakova J, Telicka Z, Antosova M, Limanova Z, et al. Thyroid nodules: pathophysiological insight on oncogenesis and novel diagnostic techniques. Physiol Res. 2014; 63 Suppl 2-75[PubMed]
  • 10. Gul K, Ersoy R, Dirikoc A, Korukluoglu B, Ersoy PE, Aydin R, et al. Ultrasonographic evaluation of thyroid nodules: comparison of ultrasonographic, cytological, and histopathological findings. Endocrine. 2009; 36(3): 464-72[DOI][PubMed]
  • 11. Salmaslioglu A, Erbil Y, Dural C, Issever H, Kapran Y, Ozarmagan S, et al. Predictive value of sonographic features in preoperative evaluation of malignant thyroid nodules in a multinodular goiter. World J Surg. 2008; 32(9): 1948-54[DOI][PubMed]
  • 12. Kwak JY, Han KH, Yoon JH, Moon HJ, Son EJ, Park SH, et al. Thyroid imaging reporting and data system for US features of nodules: a step in establishing better stratification of cancer risk. Radiology. 2011; 260(3): 892-9[DOI][PubMed]
  • 13. Henrichsen TL, Reading CC, Charboneau JW, Donovan DJ, Sebo TJ, Hay ID. Cystic change in thyroid carcinoma: Prevalence and estimated volume in 360 carcinomas. J Clin Ultrasound. 2010; 38(7): 361-6[DOI][PubMed]
  • 14. Frates MC, Benson CB, Charboneau JW, Cibas ES, Clark OH, Coleman BG, et al. Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement. Radiology. 2005; 237(3): 794-800[DOI][PubMed]
  • 15. Gkountouvas A, Thomas D, Tertipi A, Chrysanthou K, Kaldrimidis P. Exophytic and ulcerated local recurrence of papillary thyroid carcinoma with spectacular response to external beam radiotherapy. Thyroid. 2008; 18(9): 1015-6[DOI][PubMed]
  • 16. Spencer CA. Clinical review: Clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC). J Clin Endocrinol Metab. 2011; 96(12): 3615-27[DOI][PubMed]
  • 17. Vasileiadis I, Boutzios G, Charitoudis G, Koukoulioti E, Karatzas T. Thyroglobulin antibodies could be a potential predictive marker for papillary thyroid carcinoma. Ann Surg Oncol. 2014; 21(8): 2725-32[DOI][PubMed]
  • 18. Qin J, Yu Z, Guan H, Shi L, Liu Y, Zhao N, et al. High Thyroglobulin Antibody Levels Increase the Risk of Differentiated Thyroid Carcinoma. Dis Markers. 2015; 2015: 648670[DOI][PubMed]
  • 19. Paparodis R, Imam S, Todorova-Koteva K, Staii A, Jaume JC. Hashimoto's thyroiditis pathology and risk for thyroid cancer. Thyroid. 2014; 24(7): 1107-14[DOI][PubMed]
  • 20. Caballero Y, Lopez-Tomassetti EM, Favre J, Santana JR, Cabrera JJ, Hernandez JR. The value of thyroperoxidase as a prognostic factor for differentiated thyroid cancer -- a long-term follow-up study. Thyroid Res. 2015; 8: 12[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments